Fig. 6

Comprehensive assessment of DDR Recurrence Signature. A The RFS curve for early-stage PTC according to the ATA risk stratification. B The RFS curve for early-stage PTC according to the PBF/PTTG1 signature. C The application of the DDR signature in the entire TCGA cohort. D The application of the DDR signature in the TCGA cohort with BRAF mutation